89Zr-J591

DRUG2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University

Conditions

GlioblastomaProstate Cancer

Phase 1

Neoadjuvant J591 Treatment for Prostate Cancer

CompletedNCT02693860

Weill Medical College of Cornell UniversityProstate Cancer

Start: 2016-02-04End: 2020-02-02Updated: 2020-10-05

Unknown Phase

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

CompletedNCT02410577

Memorial Sloan Kettering Cancer CenterGlioblastoma

Start: 2015-04-30End: 2018-08-31Updated: 2019-03-19